secwatch.observer — SEC 8-K summary
======================================

Issuer:     VACCINEX, INC. (VCNX)
CIK:        0001205922
Form:       8-K
Filed at:   2022-10-11T23:59:59+00:00
Accession:  0001193125-22-260706
Event type: regulatory
Sentiment:  negative
Materiality: 0.70
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Vaccinex receives Nasdaq delisting notice for bid price below $1.00
-------------------------------------------------------------------

- Nasdaq letter on Oct 10, 2022: common stock bid price below $1.00 for 30 consecutive days through Oct 7.
- Company has 180 days (until April 10, 2023) to regain compliance by closing at $1.00+ for 10 business days.
- If not cured, may seek second 180-day period if meeting other listing standards; otherwise delisting risk.
- Company to monitor bid price and evaluate options including reverse stock split to cure.
- No immediate effect on listing; appeal rights exist if delisting notice issued.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1205922/000119312522260706/0001193125-22-260706-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1205922/000119312522260706/d393979d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-260706

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer